» Articles » PMID: 8070608

Toxicity of Mildly Modified Low-density Lipoproteins to Cultured Retinal Capillary Endothelial Cells and Pericytes

Overview
Journal Diabetes
Specialty Endocrinology
Date 1994 Sep 1
PMID 8070608
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the role of modified low-density lipoproteins (LDL) in the pathogenesis of diabetic retinopathy, we studied the cytotoxicity of normal and mildly modified human LDL to bovine retinal capillary endothelial cells and pericytes in vitro. Pooled LDL was incubated (in phosphate-buffered saline-EDTA, 3 days, 37 degrees C) under 1) nitrogen with additional chelating agents and 2) air, to prepare normal and minimally oxidized LDL, respectively. Similar conditions, but with the addition of 50 mM D-glucose, were used to prepare glycated and glycoxidized LDL. None of the LDL preparations was recognized by the macrophage scavenger receptor, confirming limited modification. Retinal capillary endothelial cells and pericytes were grown to confluence and then exposed for 2 or 3 days to serum-free medium (1% albumin) supplemented with normal or modified LDL (100 mg/l) or to serum-free medium alone. Cytotoxicity was assessed by cell counting (live and total cells) and by cell protein determination. Compared with normal LDL, modified LDL were cytotoxic to both cell types at both time points, causing highly significant decreases in live and total cell counts (P < 0.001) (analysis of variance). Reductions in cell protein also were significant for pericytes at day 3 (P = 0.016) and of borderline significance for endothelial cells at day 2 (P = 0.05) and day 3 (P = 0.063). Cytotoxicity increased as follows: normal < glycated < or = minimally oxidized < glycoxidized LDL. We conclude that, in diabetes, mild modification of LDL resulting from separate or combined processes of glycation and oxidation may contribute to chronic retinal capillary injury and thus to the development of diabetic retinopathy.

Citing Articles

Synergism of mechanisms underlying early-stage changes in retina function in male hyperglycemic db/db mice in the absence and presence of chemically-induced dyslipidemia.

Johnston T, Edwards G, Koulen P Sci Rep. 2023; 13(1):17347.

PMID: 37833428 PMC: 10576038. DOI: 10.1038/s41598-023-44446-3.


Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Aluganti Narasimhulu C, Parthasarathy S Methods Mol Biol. 2022; 2419:213-246.

PMID: 35237967 DOI: 10.1007/978-1-0716-1924-7_13.


Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.

Fu D, Yu J, Connell A, Hookham M, McLeese R, Lyons T J Ocul Pharmacol Ther. 2020; 36(10):754-764.

PMID: 33107777 PMC: 7757531. DOI: 10.1089/jop.2020.0068.


The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.

Puchalowicz K, Rac M Cells. 2020; 9(8).

PMID: 32796572 PMC: 7465275. DOI: 10.3390/cells9081877.


Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes.

Rosta V, Trentini A, Passaro A, Zuliani G, Sanz J, Bosi C Antioxidants (Basel). 2020; 9(8).

PMID: 32751395 PMC: 7463677. DOI: 10.3390/antiox9080683.